Administration Proposal Would Increase Competition, Transparency and Value — Reform Medicare Part D to Protect Seniors and Taxpayers
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to the release of a comprehensive plan to lower prescription drug prices from U.S. Department of Health & Human Services (HHS) Secretary Xavier Becerra. The plan was commissioned as part of a July executive order from President Biden on “Promoting Competition in the American Economy.”
“CSRxP applauds President Biden and Secretary Becerra for demonstrating the administration’s ongoing commitment to lowering prescription drug prices and holding Big Pharma accountable,” said CSRxP executive director Lauren Aronson. “Secretary Becerra’s plan adds to the unprecedented momentum for action in Washington to crack down on the egregious price-gouging and anti-competitive practices of Big Pharma and provide relief for the millions of Americans struggling to afford their medications.”
“CSRxP has been a longtime advocate for many of the solutions included in the administration’s plan, including measures to boost competition and transparency, promote greater value in the system and reform Medicare Part D to cap out-of-pocket costs for seniors, limit the pace of Big Pharma’s price increases and hold manufacturers accountable,” Aronson continued. “CSRxP looks forward to continuing to work with the administration and Congress to ensure these and additional critical solutions advance.”
Read more on the U.S. Department of Health & Human Services Proposal to Lower Prescription Drug Costs HERE.
Learn more on market-based solutions to hold Big Pharma accountable and lower prescription drug prices HERE.